As a protein ligand, NTF3 pays special attention to the binding process of ligand and protein in drug design, and we, therefore, expect to develop drugs targeting NTF3 for the treatment of HCC in the future. The gene discussed is NTF3; the disease is hepatocellular carcinoma.